Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thromboserin versus placebo during coronary artery bypass grafting
ISRCTN59071456Phase 2Terminated
- Sponsor
- Imperial College London
- Start
- Jan 2009
- Modality
- Small Molecules
01
Overview
Phase 2, randomised trial in cardiac morbidity comparing Thromboserin with Placebo (2 arms). Primary endpoint: Platelet aggregate and thrombus growth. Started Jan 2009; status: terminated.
02
Drugs
thromboserin
03
Conditions
cardiac morbidity
Beyond the preview
Go deeper on ISRCTN59071456.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN59071456.